Neuroprotection and acute spinal cord injury: A reappraisal (original) (raw)

• Anderson DK, Hall ED. Pathophysiology of spinal cord trauma.Ann Emerg Med 22: 987–992, 1993.
  PubMed CAS Google Scholar
• Hall ED. Mechanisms of secondary CNS injury. In: Neurosurgery 96: manual of neurosurgery (Palmer JD, ed), pp 505–510. New York: Churchill-Livingstone, 1996.
  Google Scholar
• Hall ED, Braughler JM. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation.Free Radic Biol Med 6: 303–313, 1989.
  PubMed CAS Google Scholar
• Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms.J Neurosurg 75: 15–26, 1991.
  PubMed CAS Google Scholar
• Faden AI. Therapeutic approaches to spinal cord injury.Adv Neurol 72: 377–386, 1997.
  PubMed CAS Google Scholar
• Faden AI, Salzman S. Pharmacological strategies in CNS trauma.Trends Pharmacol Sci 13: 29–35, 1992.
  PubMed CAS Google Scholar
• Braughler JM, Hall ED. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation.Free Radic Biol Med 6: 289–301, 1989.
  PubMed CAS Google Scholar
• Hall ED, Braughler JM. Free radicals in CNS injury.Res Publ Assoc Res Nerv Ment Dis 71: 81–105, 1993.
  PubMed CAS Google Scholar
• Faden AI, Holaday JW. A role for endorphins in the pathophysiology of spinal cord injury.Adv Biochem Psychopharmacol 28: 435–446, 1981.
  PubMed CAS Google Scholar
• Reulen HJ, Schurmann K. Steroids and brain edema. Berlin: Springer, 1972.
  Google Scholar
• Bracken MB, Collins WF, Freeman DF, Shepard MJ, Silten RM, Hellenbrand KG et al. Efficacy of methylprednisolone in acute spinal cord injury.JAMA 51: 45–52, 1984.
  Google Scholar
• Bracken MB, Shepard MJ, Hellenbrand KG, Collins WF, Leo-Summers L, Freeman DF et al. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study.J Neurosurg 63: 704–713, 1985.
  PubMed CAS Google Scholar
• Demopoulos HB, Flamm ES, Pietronigro DD, Seligman ML. The free radical pathology and the microcirculation in the major central nervous system disorders.Acta Physiol Scand Suppl 492: 91–119, 1980.
  PubMed CAS Google Scholar
• Hall ED. The neuroprotective pharmacology of methylprednisolone.J Neurosurg 76: 13–22, 1992.
  PubMed CAS Google Scholar
• Hall ED, Braughler JM. Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue.Exp Neurol 73: 321–324, 1981.
  PubMed CAS Google Scholar
• Hall ED, Braughler JM. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale.Surg Neurol 18: 320–327, 1982.
  PubMed CAS Google Scholar
• Hall ED. Glucocorticoid effects on central nervous excitability and synaptic transmission.Int Rev Neurobiol 23: 165–195, 1982.
  PubMed CAS Google Scholar
• Hall ED, Wolf DL, Braughler JM. Effects of a single large dose of methylprednisolone sodium succinate on experimental post-traumatic spinal cord ischemia: dose-response and time-action analysis.J Neurosurg 61: 124–130, 1984.
  PubMed CAS Google Scholar
• Young W, Flamm ES. Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury.J Neurosurg 57: 667–673, 1982.
  PubMed CAS Google Scholar
• Anderson DK, Means ED, Waters TR, Green ES. Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment.J Neurosurg 56: 106–113, 1982.
  PubMed CAS Google Scholar
• Braughler JM, Hall ED. Lactate and pyruvate metabolism in injured cat spinal cord before and after a single large intravenous dose of methylprednisolone.J Neurosurg 59: 256–261, 1983.
  PubMed CAS Google Scholar
• Braughler JM, Hall ED. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism.J Neurosurg 61: 290–295, 1984.
  PubMed CAS Google Scholar
• Braughler JM, Hall ED. Correlation of methylprednisolone levels in cat spinal cord with its effects on (Na+ + K+)-ATPase, lipid peroxidation, and alpha motor neuron function.J Neurosurg 56: 838–844, 1982.
  PubMed CAS Google Scholar
• Braughler JM, Hall ED. Uptake and elimination of methylprednisolone from contused cat spinal cord following intravenous injection of the sodium succinate ester.J Neurosurg 58: 538–542, 1983.
  PubMed CAS Google Scholar
• Anderson DK, Saunders RD, Demediuk P et al. Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium.Cent Nerv Syst Trauma 2: 257–267, 1985.
  PubMed CAS Google Scholar
• Braughler JM, Hall ED, Means ED, Waters TR, Anderson DK. Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury.J Neurosurg 67: 102–105, 1987.
  PubMed CAS Google Scholar
• Taoka Y, Okajima K, Uchiba M, Johno M. Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-α production.J Neurotrauma 18: 533–543, 2001.
  PubMed CAS Google Scholar
• Farooque M, Hillered L, Holtz A, Olsson Y. Effects of methylprednisolone on extracellular lactic acidosis and amino acids after severe compression injury of rat spinal cord.J Neurochem 66: 1125–1130, 1996.
  PubMed CAS Google Scholar
• Holtz A, Nystrom B, Gerdin B. Effect of methylprednisolone on motor function and spinal cord blood flow after spinal cord compression in rats.Acta Neurol Scand 82: 68–73, 1990.
  PubMed CAS Google Scholar
• Xu J, Qu ZX, Hogan EL, Perot PL Jr. Protective effect of methylprednisolone on vascular injury in rat spinal cord injury.J Neurotrauma 9: 245–253, 1992.
  PubMed CAS Google Scholar
• Xu J, Kim GM, Ahmed SH, Yan P, Xu XM, Hsu CY. Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury.J Neurosci 21: 92–97, 2001.
  PubMed CAS Google Scholar
• Behrmann DL, Bresnahan JC, Beattie MS. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673.Exp Neurol 126: 61–75, 1994.
  PubMed CAS Google Scholar
• Koyanagi I, Tator CH. Effect of a single huge dose of methylprednisolone on blood flow, evoked potentials, and histology after acute spinal cord injury in the rat.Neurol Res 19: 289–299, 1997.
  PubMed CAS Google Scholar
• Rabchevsky AG, Fugaccia I, Sullivan PG, Blades DA, Scheff SW. Efficacy of methylprednisolone therapy for the injured rat spinal cord.J Neurosci Res 68: 7–18, 2002.
  PubMed CAS Google Scholar
• Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: The pharmacological basis of therapeutics, Ed 10 (Hardman JG, Limberd LE, Gilman, AG, eds), pp 1649–1677. New York: McGraw-Hill, 2001.
  Google Scholar
• Hall ED, McCall JM, Chase RL, Yonkers PA, Braughler JM. A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage.J Pharmacol Exp Ther 242: 137–142, 1987.
  PubMed CAS Google Scholar
• Braughler JM. Lipid peroxidation-induced inhibition of gamma-aminobutyric acid uptake in rat brain synaptosomes: protection by glucocorticoids.J Neurochem 44: 1282–1288, 1985.
  PubMed CAS Google Scholar
• Holaday JW, Faden AI. Naloxone reverses the pathophysiology of shock through an antagonism of endorphin systems.Adv Biochem Psychopharmacol 28: 421–434, 1981.
  PubMed CAS Google Scholar
• Holaday JW, Faden AI. Naloxone treatment in shock.Lancet 2: 201, 1981.
  PubMed CAS Google Scholar
• Flamm ES, Young W, Demopoulos HB, DeCrescito V, Tomasula JJ. Experimental spinal cord injury: treatment with naloxone.Neurosurgery 10: 227–231, 1982.
  PubMed CAS Google Scholar
• Faden AI, Jacobs TP, Holaday JW. Opiate antagonist improves neurologic recovery after spinal injury.Science 211: 493–494, 1981.
  PubMed CAS Google Scholar
• Faden AI, Jacobs TP, Holaday JW. Comparison of early and late naloxone treatment in experimental spinal injury.Neurology 32: 677–681, 1982.
  PubMed CAS Google Scholar
• Flamm ES, Young W, Collins WF, Piepmeier J, Clifton GL, Fischer B. A phase I trial of naloxone treatment in acute spinal cord injury.J Neurosurg 63: 390–397, 1985.
  PubMed CAS Google Scholar
• Bracken MB, Shepard MJ, Collins WF et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.N Engl J Med 322: 1405–1411, 1990.
  PubMed CAS Google Scholar
• Bracken MB, Shepard MJ, Collins WF Jr et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study.J Neurosurg 76: 23–31, 1992.
  PubMed CAS Google Scholar
• Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2.J Neurosurg 79: 500–507, 1993.
  PubMed CAS Google Scholar
• Bracken MB. Pharmacological treatment of acute spinal cord injury: current status and future projects.J Emerg Med 11[Suppl 1]: 43–48, 1993.
  PubMed Google Scholar
• Anderson DK, Saunders RD, Demediuk P, Dugan LL, Braughler JM, Hall ED. Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium.CNS Trauma 2: 257–268, 1986.
  Google Scholar
• Clark CR, Maclusky NJ, Naftolin F. Glucocorticoid receptors in the spinal cord.Brain Res 217: 412–415, 1981.
  PubMed CAS Google Scholar
• Hall ED, Yonkers PA, Taylor BM, Sun FF. Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord.J Neurotrauma 12: 245–256, 1995.
  PubMed CAS Google Scholar
• Bartholdi D, Schwab ME. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat.Brain Res 672: 177–186, 1995.
  PubMed CAS Google Scholar
• Popovich PG, Jones TB. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics.Trends Pharmacol Sci 24: 13–17, 2003.
  PubMed CAS Google Scholar
• Popovich PG, Wei P, Stokes BT. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats.J Comp Neurol 377: 443–464, 1997.
  PubMed CAS Google Scholar
• Popovich PG, Stokes BT, Whitacre CC. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system.J Neurosci Res 45: 349–363, 1996.
  PubMed CAS Google Scholar
• Popovich PG, Yu JY, Whitacre CC. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein.J Neuropathol Exp Neurol 56: 1323–1338, 1997.
  PubMed CAS Google Scholar
• Hall ED. Lazaroid: mechanisms of action and implications for disorders of the CNS.Neuroscientist 3: 42–51, 1997.
  CAS Google Scholar
• Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage.Adv Pharmacol 28: 221–268, 1994.
  PubMed CAS Google Scholar
• Braughler JM, Chase RL, Neff GL, Yonkers PA, Day JS, Hall ED et al. A new 21-aminosteroid antioxidant lacking glucocorticoid activity stimulates adrenocorticotropin secretion and blocks ara-chidonic acid release from mouse pituitary tumor (AtT-20) cells.J Pharmacol Exp Ther 244: 423–427, 1988.
  PubMed CAS Google Scholar
• Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazi M et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial.JAMA 77: 1597–1604, 1997.
  Google Scholar
• Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazi M et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial.J Neurosurg 89: 699–706, 1998.
  PubMed CAS Google Scholar
• Galandiuk S, Raque G, Appel S, Polk HC Jr. The two-edged sword of large-dose steroids for spinal cord trauma.Ann Surg 218: 419–427, 1993.
  PubMed CAS Google Scholar
• Del Rosario Molano M, Broton JG, Bean JA, Calancie B. Complications associated with the prophylactic use of methylprednisolone during surgical stabilization after spinal cord injury.J Neurosurg 96[Suppl 3]: 267–272, 2002.
  Google Scholar
• Bracken MB. Methylprednisolone and acute spinal cord injury: an update of the randomized evidence.Spine 26[Suppl 24]: 47–54, 2001.
  Google Scholar
• Scheff SW, Benardo LS, Cotman CW. Hydrocortison administration retards axon sprouting in the rat dentate gyrus.Exp Neurol 68: 195–201, 1980.
  PubMed CAS Google Scholar
• Scheff SW, Cotman CW. Chronic glucocorticoid therapy alters axon sprouting in the hippocampal dentate gyrus.Exp Neurol 76: 644–654, 1982.
  PubMed CAS Google Scholar
• Scheff SW, DeKosky ST. Steroid suppression of axon sprouting in the hippocampal dentate gyrus of the adult rat: dose-response relationship.Exp Neurol 82: 183–191, 1983.
  PubMed CAS Google Scholar
• Scheff SW, Dekosky ST. Glucocorticoid suppression of lesion-induced synaptogenesis: effect of temporal manipulation of steroid treatment.Exp Neurol 105: 260–264, 1989.
  PubMed CAS Google Scholar
• Sapolsky RM. Glucocorticoid toxicity in the hippocampus: temporal aspects of neuronal vulnerability.Brain Res 359: 300–305, 1985.
  PubMed CAS Google Scholar
• Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.Endocr Rev 7: 284–301, 1986.
  PubMed CAS Google Scholar
• McIntosh LJ, Sapolsky RM. Glucocorticoids may enhance oxygen radical-mediated neurotoxicity.Neurotoxicology 17: 873–882, 1996.
  PubMed CAS Google Scholar
• Landfield PW, Eldridge JC. The glucocorticoid hypothesis of age-related hippocampal neurodegeneration: role of dysregulated intraneuronal calcium.Ann NY Acad Sci 746: 308–326, 1994.
  PubMed CAS Google Scholar
• Elliott EM, Sapolsky RM. Corticosterone enhances kainic acid-induced calcium elevation in cultured hippocampal neurons.J Neurochem 59: 1033–1040, 1992.
  PubMed CAS Google Scholar
• Dinkel K, MacPherson A, Sapolsky RM. Novel glucocorticoid effects on acute inflammation in the CNS.J Neurochem 84: 705–716, 2003.
  PubMed CAS Google Scholar
• Morse JK, Davis JN. Regulation of ischemic hippocampal damage in the gerbil: adrenalectomy alters the rate of CA1 cell disappearance.Exp Neurol 110: 86–92, 1990.
  PubMed CAS Google Scholar
• Shin CY, Choi JW, Jang ES, Ryu JH, Kim WK, Kim HC et al. Glucocorticoids exacerbate peroxynitrite mediated potentiation of glucose deprivation-induced death of rat primary astrocytes.Brain Res 923: 163–171, 2001.
  PubMed CAS Google Scholar
• Stein-Behrens BA, Elliott EM, Miller CA, Schilling JW, Newcombe R, Sapolsky RM. Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus.J Neurochem 58: 1730–1735, 1992.
  PubMed CAS Google Scholar
• Oudega M, Vargas CG, Weber AB, Kleitman N, Bunge MB. Long-term effects of methylprednisolone following transection of adult rat spinal cord.Eur J Neurosci 11: 2453–2464, 1999.
  PubMed CAS Google Scholar
• Chen A, Xu XM, Kleitman N, Bunge MB. Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord.Exp Neurol 138: 261–276, 1996.
  PubMed CAS Google Scholar
• Li X, Oudega M, Dancausse HA, Levi AD. The effect of methylprednisolone on caspase-3 activation after rat spinal cord transection.Restor Neurol Neurosci 17: 203–209, 2000.
  PubMed Google Scholar
• Ray SK, Wilford GG, Matzelle DC, Hogan EL, Banik NL. Calpeptin and methylprednisolone inhibit apoptosis in rat spinal cord injury.Ann NY Acad Sci 890: 261–269, 1999.
  PubMed CAS Google Scholar
• Kanellopoulos GK, Kato H, Wu Y, Dougenis D, Mackey M, Hsu CY et al. Neuronal cell death in the ischemic spinal cord: the effect of methylprednisolone.Ann Thorac Surg 64: 1279–1286, 1997.
  PubMed CAS Google Scholar
• Diem R, Hobom M, Maier K, Weissert R, Storch MK, Meyer R et al. Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway.J Neurosci 23: 6993–7000, 2003.
  PubMed CAS Google Scholar
• Gorio A. Ganglioside enhancement of neuronal differentiation, plasticity, and repair.CRC Crit Rev Clin Neurobiol 2: 241–296, 1986.
  PubMed CAS Google Scholar
• Gorio A, Vitadello M. Ganglioside prevention of neuronal functional decay.Prog Brain Res 71: 203–208, 1987.
  PubMed CAS Google Scholar
• Gorio A. Gangliosides as a possible treatment affecting neuronal repair processes.Adv Neurol 47: 523–530, 1988.
  PubMed CAS Google Scholar
• Geisler FH, Coleman WP, Grieco G, Poonian D. The Sygen multicenter acute spinal cord injury study.Spine 26[Suppl 24]: 87–98, 2001.
  Google Scholar
• Geisler FH, Dorsey FC, Coleman WP. GM1 gangliosides in the treatment of spinal cord injury: report of preliminary data analysis.Acta Neurobiol Exp (Warsz) 50: 515–521, 1990.
  CAS Google Scholar
• Geisler FH, Dorsey FC, Coleman WP. Recovery of motor function after spinal-cord injury—a randomized, placebo-controlled trial with GM-1 ganglioside.N Engl J Med 324: 1829–1838, 1991.
  PubMed CAS Google Scholar
• Geisler FH, Coleman WP, Grieco G, Poonian D. Measurements and recovery patterns in a multicenter study of acute spinal cord injury.Spine 26[Suppl 24]: 68–86, 2001.
  Google Scholar
• Geisler FH, Coleman WP, Grieco G, Poonian D. Recruitment and early treatment in a multicenter study of acute spinal cord injury.Spine 26[Suppl 24]: 58–67, 2001.
  Google Scholar
• Bracken MB, Holford TR. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III.J Neurosurg 96[Suppl 3]: 259–266, 2002.
  PubMed Google Scholar
• Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care.J Neurosurg 93[Suppl 1]: 1–7, 2000.
  PubMed CAS Google Scholar
• Short DJ, El Masry WS, Jones PW. High-dose methylprednisolone in the management of acute spinal cord injury—a systematic review from a clinical perspective.Spinal Cord 38: 273–286, 2000.
  PubMed CAS Google Scholar
• Coleman WP, Benzel D, Cahill DW, Ducker T, Geisler F, Green B et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury.J Spinal Disord 13: 185–199, 2000.
  PubMed CAS Google Scholar
• Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.Neurology 55: 1649–1655, 2000.
  PubMed CAS Google Scholar
• Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.N Engl J Med 340: 1781–1787, 1999.
  PubMed CAS Google Scholar
• Fehlings MG. Summary statement: the use of methylprednisolone in acute spinal cord injury._Spine 26_[_Suppl_ 24: 55, 2001.
  Google Scholar
• Fehlings MG. Editorial: recommendations regarding the use of methylprednisolone in acute spinal cord injury: making sense out of the controversy.Spine 26[Suppl 24): 56–57, 2001.
  Google Scholar
• Otani K, Abe H, Kadoya S. Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury (in Japanese).Sekitsui Sekizui 7: 633–647, 1994.
  Google Scholar
• Petitjean ME, Pointillart V, Dixmerias F. Medical treatment of spinal cord injury in the acute stage (in French).Ann Fr Anesth Reanim 17: 114–122, 1998.
  PubMed CAS Google Scholar
• Hurlbert RJ. Methyprednisolone for acute spinal cord injury: reevaluating the NASCIS trials.J Spinal Cord Med 25: 206, 2002.
  Google Scholar
• Constantini S, Young W. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats.J Neurosurg 80: 97–111, 1994.
  PubMed CAS Google Scholar
• Bao F, Liu D. Peroxynitrite generated in the rat spinal cord induces apoptotic cell death and activates caspase-3.Neuroscience 116: 59–70, 2003.
  PubMed CAS Google Scholar
• Xu J, Gyeong-Moon K, Chen S, Yan P, Hinan A, Ku G et al. iNOS and nitrotyrosine expression after spinal cord injury.J Neurotrauma 18: 523–532, 2001.
  PubMed CAS Google Scholar
• Beckman JS. The double-edged role of nitric oxide in brain function and superoxide-mediated injury.J Dev Physiol 15: 53–59, 1991.
  PubMed CAS Google Scholar
• Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide.Arch Biochem Biophys 288: 481–487, 1991.
  PubMed CAS Google Scholar
• Carroll RT, Galatsis P, Borosky S, Kopec KK, Kumar V, Althaus JS et al. 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol) inhibits peroxynitrite-mediated phenol nitration.Chem Res Toxicol 13: 294–300, 2000.
  PubMed CAS Google Scholar
• Hall ED, Kupina NC, Althaus JS. Peroxynitrite scavengers for the acute treatment of traumatic brain injury.Ann NY Acad Sci 890: 462–468, 1999.
  PubMed CAS Google Scholar
• Chabrier PE, Auguet M, Spinnewyn B, Auvin S, Cornet S, Demerle-Pallardy C et al. BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuro-protective strategy.Proc Natl Acad Sci USA 96: 10824–10829, 1999.
  PubMed CAS Google Scholar
• Tonai T, Taketani Y, Ohmoto Y, Ueda N, Nishisho T, Yamamoto S. Cyclooxygenase-2 induction in rat spinal cord injury mediated by proinflammatory tumor necrosis factor-alpha and interleukin-1.Adv Exp Med Biol 507: 397–401, 2002.
  PubMed CAS Google Scholar
• Schwab JM, Brechtel K, Nguyen TD, Schluesener HJ. Persistent accumulation of cyclooxygenase-1 (COX-1) expressing micro-glia/macrophages and upregulation by endothelium following spinal cord injury.J Neuroimmunol 111: 122–130, 2000.
  PubMed CAS Google Scholar
• Resnick DK, Graham SH, Dixon CE, Marion DW. Role of cyclooxygenase 2 in acute spinal cord injury.J Neurotrauma 15: 1005–1013, 1998.
  PubMed CAS Google Scholar
• Hoffmann C. COX-2 in brain and spinal cord implications for therapeutic use.Curr Med Chem 7: 1113–1120, 2000.
  PubMed CAS Google Scholar
• Hains BC, Yucra JA, Hulsebosch CE. Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398.J Neurotrauma 18: 409–423, 2001.
  PubMed CAS Google Scholar
• Yuen PW, Wang KKW. Therapeutic potential of calpain inhibitors in neurodegenerative disorder.Expert Opin Investig Drugs 5: 1291–1304, 1996.
  CAS Google Scholar
• Yuen P, Wang KW. Calpain inhibitors: novel neuroprotectants and potential anticataract agents.Drugs Future 23: 741–749, 1998.
  CAS Google Scholar
• Wingrave JM, Schaecher KE, Sribnick EA, Wilford GG, Ray SK, Hazen-Martin DJ et al. Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats.J Neurosci Res 73: 95–104, 2003.
  PubMed CAS Google Scholar
• Ray SK, Hogan EL, Banik NL. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors.Brain Res Rev 42: 169–185, 2003.
  PubMed CAS Google Scholar
• Ray SK, Matzelle DD, Wilford GG, Hogan EL, Banik NL. Inhibition of calpain-mediated apoptosis by E-64 d-reduced immediate early gene (IEG) expression and reactive astrogliosis in the lesion and penumbra following spinal cord injury in rats.Brain Res Rev 916: 115–126, 2001.
  CAS Google Scholar
• Ray SK, Matzelle DD, Wilford GG, Hogan EL, Banik NL. Cell death in spinal cord injury (SCI) requires de novo protein synthesis: calpain inhibitor E-64-d provides neuroprotection in SCI lesion and penumbra.Ann NY Acad Sci 939: 436–449, 2001.
  PubMed CAS Google Scholar
• Ray SK, Matzelle DD, Wilford GG, Hogan EL, Banik NL. Increased calpain expression is associated with apoptosis in rat spinal cord injury: calpain inhibitor provides neuroprotection.Neurochem Res 25: 1191–1198, 2000.
  PubMed CAS Google Scholar
• Shields DC, Schaecher KE, Hogan EL, Banik NL. Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion.J Neurosci Res 61: 146–150, 2000.
  PubMed CAS Google Scholar
• Banik NL, Shields DC. The role of calpain in neurofilament protein degradation associated with spinal cord injury.Methods Mol Biol 144: 195–201, 2000.
  PubMed CAS Google Scholar
• Zhang SX, Bondada V, Geddes JW. Evaluation of conditions for calpain inhibition in the rat spinal cord: effective postinjury inhibition with intraspinal MDL28170 microinjection.J Neurotrauma 20: 59–67, 2003.
  PubMed Google Scholar
• Faden AI, Jacobs TP, Holaday JW. Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats.N Engl J Med 305: 1063–1067, 1981.
  PubMed CAS Google Scholar
• Faden AI, Sacksen I, Noble LJ. Structure-activity relationships of TRH analogs in rat spinal cord injury.Brain Res 448: 287–293, 1988.
  PubMed CAS Google Scholar
• Pitts LH, Ross A, Chase GA, Faden AI. Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries.J Neurotrauma 12: 235–243, 1995.
  PubMed CAS Google Scholar
• Faden AI. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies.Brain Res 486: 228–235, 1989.
  PubMed CAS Google Scholar
• Faden AI, Fox G, Fan L, Knoblach S, Araldi GL, Kozikowski AP. Neuroprotective and cognitive enhancing effects of novel small peptides.Ann NY Acad Sci 890: 120, 1999.
  PubMed CAS Google Scholar
• Beattie MS, Farooqui AA, Bresnahan JC. Rew of current evidence for apoptosis after spinal cord injury.J Neurotrauma 17: 915–925, 2000.
  PubMed CAS Google Scholar
• Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys.Nat Med 3: 73–76, 1997.
  PubMed CAS Google Scholar
• Emery E, Aldana P, Bunge MB, Puckett W, Srinivasan A, Keane RW et al. Apoptosis after traumatic human spinal cord injury.J Neurosurg 89: 911–920, 1998.
  PubMed CAS Google Scholar
• Liu XZ, Xu XM, Hu R, Du C, Zhang SX, McDonald JW et al. Neuronal and glial apoptosis after traumatic spinal cord injury.J Neurosci 17: 5395–5406, 1997.
  PubMed CAS Google Scholar
• Lou J, Lenke LG, Ludwig FJ, O’Brien MF. Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury.Spinal Cord 36: 683–690, 1998.
  PubMed CAS Google Scholar
• Shuman SL, Bresnahan JC, Beattie MS. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats.J Neurosci Res 50: 798–808, 1997.
  PubMed CAS Google Scholar
• Takagi T, Takayasu M, Mizuno M, Yoshimoto M, Yoshida J. Caspase activation in neuronal and glial apoptosis following spinal cord injury in mice.Neurol Med Chir (Tokyo) 43: 20–30, 2003.
  Google Scholar
• Yong C, Arnold PM, Zoubine MN, Citron BA, Watanabe I, Berman NE et al. Apoptosis in cellular compartments of rat spinal cord after severe contusion injury.J Neurotrauma 15: 459–472, 1998.
  PubMed CAS Google Scholar
• Beattie MS, Hermann GE, Rogers RC, Bresnahan JC. Cell death in models of spinal cord injury.Prog Brain Res 137: 37–47, 2002.
  PubMed Google Scholar
• Citron BA, Arnold PM, Sebastian C, Qin F, Malladi S, Ameenuddin S et al. Rapid upregulation of caspase-3 in rat spinal cord after injury: mRNA, protein, and cellular localization correlates with apoptotic cell death.Exp Neurol 166: 213–226, 2000.
  PubMed CAS Google Scholar
• Li M, Ona VO, Chen M, Kaul M, Tenneti L, Zhang X et al. Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury.Neuroscience 99: 333–342, 2000.
  PubMed CAS Google Scholar
• Springer JE, Nottingham SA, McEwen ML, Azbill RD, Jin Y. Caspase-3 apoptotic signaling following injury to the central nervous system.Clin Chem Lab Med 39: 299–307, 2001.
  PubMed CAS Google Scholar
• Springer J, Azbill R, Knapp P. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury.Nat Med 5: 943–946, 1999.
  PubMed CAS Google Scholar
• Chen J, Nagayama T, Jin K, Stetler RA, Zhu RL, Graham SH et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia.J Neurosci 18: 4914–4928, 1998.
  PubMed CAS Google Scholar
• Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gomez-Isla T et al. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.J Cereb Blood Flow Metab 18: 238–247, 1998.
  PubMed CAS Google Scholar
• Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.Proc Natl Acad Sci USA 94: 2007–2012, 1997.
  PubMed CAS Google Scholar
• Ni B, Wu X, Su Y, Smalstig EB, Clemens J, Paul SM et al. Transient global forebrain ischemia induces a prolonged expression of the caspase-3 mRNA in rat hippocampal CA1 pyramidal neurons.J Cereb Blood Flow Metab 18: 248–256, 1998.
  PubMed CAS Google Scholar
• Pike BR, Zhao X, Newcomb JK, Posmantur RM, Wang KK, Hayes RL. Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury.Neuroreport 9: 2437–2442, 1998.
  PubMed CAS Google Scholar
• Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AI. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury.J Neurosci 17: 7415–7424, 1997.
  PubMed CAS Google Scholar
• Clark RS, Kochanek PM, Watkins SC, Chen M, Dixon CE, Seidberg NA et al. Caspase-3 mediated neuronal death after traumatic brain injury in rats.J Neurochem 74: 740–753, 2000.
  PubMed CAS Google Scholar
• Eldadah BA, Faden AI. Caspase pathways, neuronal apoptosis, and CNS injury.J Neurotrauma 17: 811–829, 2000.
  PubMed CAS Google Scholar
• Velier JJ, Ellison JA, Kikly KK, Spera PA, Barone FC, Feuerstein GZ. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat.J Neurosci 19: 5932–5941, 1999.
  PubMed CAS Google Scholar
• Zhang C, Raghupathi R, Saatman K, LaPlaca M, McIntosh T. Regional and temporal alterations in DNA fragmentation factor (DFF)-like proteins following experimental brain trauma in the rat.J Neurochem 73: 1650–1659, 1999.
  PubMed CAS Google Scholar
• Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization.EMBO J 17: 37–49, 1998.
  PubMed CAS Google Scholar
• Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.Cell 102: 33–42, 2000.
  PubMed CAS Google Scholar
• Kluck RM, Martin SJ, Hoffman BM, Zhou JS, Green DR, Newmeyer DD. Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system.EMBO J 16: 4639–4649, 1997.
  PubMed CAS Google Scholar
• Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.Cell 86: 147–157, 1996.
  PubMed CAS Google Scholar
• Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins.Cell 102: 43–53, 2000.
  PubMed CAS Google Scholar
• Holcik M, Gibson H, Korneluk RG. XIAP: Apoptotic brake and promising therapeutic target.Apoptosis 6: 253–261, 2001.
  PubMed CAS Google Scholar
• Ekert PG, Silke J, Hawkins CJ, Verhagen AM, Vaux DL. DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9.J Cell Biol 152: 483–490, 2001.
  PubMed CAS Google Scholar
• Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis.Nature 410: 112–116, 2001.
  PubMed CAS Google Scholar
• Wu G, Chai J, Suber TL et al. Structural basis of IAP recognition by Smac/DIABLO.Nature 408: 1008–1012, 2000.
  PubMed CAS Google Scholar
• Chai J, Du C, Wu JW, Kyin S, Wang X, Shi Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO.Nature 406: 855–862, 2000.
  PubMed CAS Google Scholar
• Parrish J, Li L, Klotz K, Ledwich D, Wang X, Xue D. Mitochondrial endonuclease G is important for apoptosis in C. elegans.Nature 412: 90–94, 2001.
  PubMed CAS Google Scholar
• Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria.Nature 412: 95–99, 2001.
  PubMed CAS Google Scholar
• Cande C, Cohen I, Daugas E, Ravagnan L, Larochette M, Zamzami N et al. Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria.Biochimie 84: 215–222, 2002.
  PubMed CAS Google Scholar
• Lorenzo HK, Susin SA, Penninger J, Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death.Cell Death Differ 6: 516–524, 1999.
  PubMed CAS Google Scholar
• Daugas E, Nochy D, Ravagnan L, Loeffler M, Susin SA, Zamzami N et al. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis.FEBS Lett 476: 118–123, 2000.
  PubMed CAS Google Scholar
• Ozawa H, Keane RW, Marcillo AE, Diaz PH, Dietrich WD. Therapeutic strategies targeting caspase inhibition following spinal cord injury in rats.Exp Neurol 177: 306–313, 2002.
  PubMed CAS Google Scholar
• Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.Cell 91: 231–241, 1997.
  PubMed CAS Google Scholar
• Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt.Science 275: 661–665, 1997.
  PubMed CAS Google Scholar
• Flores AI, Mallon BS, Matsui T, Ogawa W, Rosenzweig A, Okamoto T et al. Akt-mediated survival of oligodendrocytes induced by neuregulins.J Neurosci 20: 7622–7630, 2000.
  PubMed CAS Google Scholar
• Goswami R, Kilkus J, Dawson SA, Dawson G. Overexpression of akt (protein kinase B) confers protection against apoptosis and prevents formation of ceramide in response to pro-apoptotic stimuli.J Neurosci Res 57: 884–893, 1999.
  PubMed CAS Google Scholar
• Kennedy SG, Kandel ES, Cross TK, Hay N. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria.Mol Cell Biol 19: 5800–5810, 1999.
  PubMed CAS Google Scholar
• Nunez G, del Peso L. Linking extracellular survival signals and the apoptotic machinery.Curr Opin Neurobiol 8: 613–618, 1998.
  PubMed CAS Google Scholar
• Chen RH, Su YH, Chuang RL, Chang TY. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.Oncogene 17: 1959–1968, 1998.
  PubMed CAS Google Scholar
• Crowder RJ, Freeman RS. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons.J Neurosci 18: 2933–2943, 1998.
  PubMed CAS Google Scholar
• Eves EM, Xiong W, Bellacosa A, Kennedy SG, Tsichlis PN, Rosner MR et al. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line.Mol Cell Biol 18: 2143–2152, 1998.
  PubMed CAS Google Scholar
• Kermer P, Klocker N, Labes M, Bahr M. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo.J Neurosci 20: 2–8, 2000.
  PubMed CAS Google Scholar
• Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.Science 267: 2003–2006, 1995.
  PubMed CAS Google Scholar
• Duckett CS, Li F, Wang Y, Tomaselli KJ, Thompson CB, Armstrong RC. Human IAP-like protein regulates programmed cell death downstream of Bcl-xL and cytochrome c.Mol Cell Biol 18: 608–615, 1998.
  PubMed CAS Google Scholar
• Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases.EMBO J 17: 2215–2223, 1998.
  PubMed CAS Google Scholar
• Ekert PG, Silke J, Vaux DL. Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: optimal caspase substrates are not necessarily optimal inhibitors.EMBO J 18: 330–338, 1999.
  PubMed CAS Google Scholar
• Salvesen GS, Duckett CS. IAP proteins: blocking the road to death’s door.Nat Rev Mol Cell Biol 3: 401–410, 2002.
  PubMed CAS Google Scholar
• Hay BA, Wassarman DA, Rubin GM. Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death.Cell 83: 1253–1262, 1995.
  PubMed CAS Google Scholar
• Hay BA. Understanding IAP function and regulation: a view from Drosophila.Cell Death Differ 7: 1045–1056, 2000.
  PubMed CAS Google Scholar
• Head MS, Ryan MD, Lee D, Feng Y, Janson CA, Concha NA et al. Structure-based combinatorial library design: discovery of non-peptidic inhibitors of caspases 3 and 8.J Comput Aided Mol Des 15: 1105–1117, 2001.
  PubMed CAS Google Scholar